Leo has always stated that IPIX knew the value of B and would not sell/license for less then it’s worth. Proving the value to potential buyers has always meant proving the breadth of the platform, proving efficacy in multiple indications. Successful Ph2 trials in OM, IBD, Antibiotics and Antiviral will complete the demonstration effort.